Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial The ideas and opinions expressed ...
MADISON, Wis. (WMTV) - Pediatric oncologist and researcher Dr. Christian Capitini was named the new director of the UW Carbone Cancer Center. Capitini said the new role is both a personal milestone ...
New research indicates that many patients with advanced cancer report receiving treatment focusing on longevity over comfort, even when their goal is the opposite. The findings are published in Cancer ...
A significant discordance exists between patient preferences and received care in advanced cancer, with 37% receiving life-extending treatment despite preferring comfort-focused care. No survival ...
After breast cancer and spouse’s prostate cancer, priorities shifted toward long-term survivorship, early retirement, and intentional family- and travel-centered goal setting. A self-authored ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results